thegreenhand
Bluelight Crew
New CDC guidelines a ‘corrective’ for opioid prescriptions, specialist says
Alvin PowellHarvard Gazette
21 Nov 2022
Excerpt:
In 2016, as the U.S. overdose epidemic raged, the Centers for Disease Control and Prevention issued prescribing guidelines that aimed to reduce excess, unused, and misused opioids. Physicians, health care systems, insurance companies, even state legislatures seized on the guidelines to reduce dosages, shorten prescriptions, or cut off patients from the drugs. But critics viewed the steps as too rigid, affecting treatment for patients dealing with severe pain.
This month, the CDC issued new guidelines that emphasize non-opioid alternatives when available, but also flexibility. Scott Hadland, chief of the Division of Adolescent and Young Adult Medicine at MassGeneral for Children and Harvard Medical School, treats substance abuse among children and adolescents. We talked to him about the new CDC guidelines in a conversation edited for clarity and length.
GAZETTE: What’s the word you would use to describe the revised guidelines, in contrast to 2016?
HADLAND: “Corrective.” The CDC has gone to great effort to highlight the flexibility that clinicians and health systems have with these 2022 guidelines, to make clear that the intent is not for people to stop receiving opioids. The guidelines expound the harms of discontinuing opioids or rapidly tapering them in someone who has been on them long-term. The 2022 guidelines focus on patient-centered care. They ask physicians to exercise caution when they prescribe opioids, and to maximize other pain treatments that are available before using opioids, but to still make opioids available in cases of acute or chronic pain in which the benefits of opioids outweigh their potential risks.